1. Home
  2. BLTE vs PAX Comparison

BLTE vs PAX Comparison

Compare BLTE & PAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • PAX
  • Stock Information
  • Founded
  • BLTE 2018
  • PAX 1988
  • Country
  • BLTE United States
  • PAX Cayman Islands
  • Employees
  • BLTE N/A
  • PAX N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • PAX Investment Managers
  • Sector
  • BLTE Health Care
  • PAX Finance
  • Exchange
  • BLTE Nasdaq
  • PAX Nasdaq
  • Market Cap
  • BLTE 2.1B
  • PAX 2.2B
  • IPO Year
  • BLTE 2022
  • PAX 2021
  • Fundamental
  • Price
  • BLTE $65.74
  • PAX $13.85
  • Analyst Decision
  • BLTE Strong Buy
  • PAX Strong Buy
  • Analyst Count
  • BLTE 4
  • PAX 1
  • Target Price
  • BLTE $96.67
  • PAX $14.00
  • AVG Volume (30 Days)
  • BLTE 39.8K
  • PAX 488.8K
  • Earning Date
  • BLTE 08-11-2025
  • PAX 11-04-2025
  • Dividend Yield
  • BLTE N/A
  • PAX 6.33%
  • EPS Growth
  • BLTE N/A
  • PAX N/A
  • EPS
  • BLTE N/A
  • PAX 0.53
  • Revenue
  • BLTE N/A
  • PAX $397,504,000.00
  • Revenue This Year
  • BLTE N/A
  • PAX N/A
  • Revenue Next Year
  • BLTE N/A
  • PAX $22.27
  • P/E Ratio
  • BLTE N/A
  • PAX $26.16
  • Revenue Growth
  • BLTE N/A
  • PAX 26.52
  • 52 Week Low
  • BLTE $43.70
  • PAX $9.43
  • 52 Week High
  • BLTE $86.53
  • PAX $14.52
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 52.03
  • PAX 57.85
  • Support Level
  • BLTE $62.18
  • PAX $13.29
  • Resistance Level
  • BLTE $66.15
  • PAX $14.05
  • Average True Range (ATR)
  • BLTE 2.66
  • PAX 0.31
  • MACD
  • BLTE -0.16
  • PAX 0.06
  • Stochastic Oscillator
  • BLTE 72.80
  • PAX 76.42

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

Share on Social Networks: